United States Pharmacopeial Convention (Usp)
Pharmaceutical quality setting organization
Based in MD
🤖
AI Overview
With $730K in lobbying spend across 16 quarterly filings, United States Pharmacopeial Convention (Usp) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2022.
$730K
Total Spend
4
Years Active
1
Firms Hired
4
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $130K |
| 2020 | $280K |
| 2021 | $200K |
| 2022 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Maintaining US support for quality standards.
- •Maintaining US support for quality pharmaceutical standards.
- •Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
United Assn of Journeymen & Apprentices of the Plumbing & Pipefitting Industry
$5.7M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Redwood Holdings, LLC FKA Redwood Capital Investments
$2.7M total spend
The United States Pharmacopeial Convention
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.